G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913 | -95.1% | 634 | -91.6% | 0.00% | – |
| Q2 2023 | $18,742 | -89.0% | 7,527 | -88.1% | 0.00% | – |
| Q1 2023 | $170,145 | -10.5% | 63,487 | +81.3% | 0.00% | – |
| Q4 2022 | $190,131 | -100.0% | 35,015 | -17.4% | 0.00% | -100.0% |
| Q3 2022 | $529,539,000 | +4925.5% | 42,397 | +1887.7% | 0.00% | – |
| Q2 2022 | $10,537,000 | -60.3% | 2,133 | -38.9% | 0.00% | – |
| Q1 2022 | $26,524,000 | -93.4% | 3,490 | -91.1% | 0.00% | -100.0% |
| Q4 2021 | $402,100,000 | +285.5% | 39,383 | +406.7% | 0.00% | – |
| Q3 2021 | $104,300,000 | +254.2% | 7,772 | +479.1% | 0.00% | – |
| Q2 2021 | $29,443,000 | -86.6% | 1,342 | -85.3% | 0.00% | – |
| Q1 2021 | $219,259,000 | +183.0% | 9,113 | +111.6% | 0.00% | – |
| Q4 2020 | $77,465,000 | -16.3% | 4,306 | -46.2% | 0.00% | – |
| Q3 2020 | $92,504,000 | +17.4% | 8,009 | +146.5% | 0.00% | – |
| Q2 2020 | $78,821,000 | -59.1% | 3,249 | -81.4% | 0.00% | – |
| Q1 2020 | $192,552,000 | +70.7% | 17,473 | +309.3% | 0.00% | – |
| Q4 2019 | $112,830,000 | -8.2% | 4,269 | -20.9% | 0.00% | – |
| Q3 2019 | $122,875,000 | +40.9% | 5,394 | +89.6% | 0.00% | – |
| Q2 2019 | $87,228,000 | +3.1% | 2,845 | -44.2% | 0.00% | – |
| Q1 2019 | $84,627,000 | +1320.9% | 5,098 | +1539.2% | 0.00% | – |
| Q4 2018 | $5,956,000 | -88.3% | 311 | -67.9% | 0.00% | – |
| Q3 2018 | $50,721,000 | +75.0% | 970 | +45.4% | 0.00% | – |
| Q2 2018 | $28,988,000 | -72.4% | 667 | -76.5% | 0.00% | – |
| Q1 2018 | $105,037,000 | +195.8% | 2,835 | +58.4% | 0.00% | – |
| Q4 2017 | $35,514,000 | +219.2% | 1,790 | +300.4% | 0.00% | – |
| Q3 2017 | $11,126,000 | – | 447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |